Citadel Advisors’s UROPLASTY INC-NEW UPI Stock Holding History

Citadel Advisors’s Portfolio UPI Stock Details UPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-17,951	Closed	-$65K	–	8680
2014 Q1	$65K	Buy	+17,951	New	+$70.1K	﹤0.01%	6562

Other funds holding UPI

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

MHP

Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCP

Rothschild Capital Partners New York $408M AUM 25.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Citadel Advisors's UPI Position: Q2 2014 in Review

Citadel Advisors sold out of UROPLASTY INC-NEW (UPI) in Q2 2014, closing a stake of 17,951 shares — an estimated $65K sold.

Citadel Advisors first reported a position in UPI in Q1 2014 and held it in 1 quarter. The position peaked at $65K in Q1 2014. 37 funds tracked by Wall St. Rank hold UPI as of Q2 2014.

Citadel Advisors reported no remaining UROPLASTY INC-NEW position as of Q2 2014 after selling out during the quarter.
Citadel Advisors sold 17,951 UROPLASTY INC-NEW shares in Q2 2014, an estimated $65K.
Citadel Advisors first reported a position in UROPLASTY INC-NEW in Q1 2014 and held it in 1 quarter.
Citadel Advisors's UROPLASTY INC-NEW position peaked at $65K in Q1 2014.
37 funds tracked by Wall St. Rank held UROPLASTY INC-NEW as of Q2 2014.

Based on Citadel Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.